Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
3,882
Views
21
CrossRef citations to date
0
Altmetric
Original Research

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma

Hai-Xia Hea State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Yan Gaoa State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Jian-Chang Fua State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;c Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Qiang-Hua Zhoud Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China;e Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaView further author information
,
Xiao-Xiao Wanga State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Bing Baia State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Peng-Fei Lia State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Cheng Huanga State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Qi-Xiang Ronga State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Li-Qin Pinga State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Yan-Xia Hea State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Jia-Ying Maoa State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Xu Chend Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China;e Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
&
Hui-Qiang Huanga State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China;b Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 1907059 | Received 02 Feb 2021, Accepted 17 Mar 2021, Published online: 07 Apr 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.